Professor Barry Clements has 35 years of respiratory clinical and research experience including previous device inventions and early phase drug development, including the founder of Respirion Pharmaceuticals, which recently raised AU$24M in Australia.

He has conducted or been the Principal Investigator in many investigator-initiated and sponsored early and late phase clinical trials. He is an experienced well-respected clinical respiratory physician with many peer review presentations and publications and has membership with national and international respiratory, cystic fibrosis and inhalation aerosol and drug delivery societies.

Professor Clements is also an Honorary Research Fellow at The Kids Research Institute Australia.